2,957 followers
RT @jamecancerdoc: 50% reduction in drug costs needed for THP followed by T-DM1 to be cost effective Rx in HER2+ MBC https://t.co/uz0AiU4Cu…
16,310 followers
RT @jamecancerdoc: 50% reduction in drug costs needed for THP followed by T-DM1 to be cost effective Rx in HER2+ MBC https://t.co/uz0AiU4Cu…
10,920 followers
50% reduction in drug costs needed for THP followed by T-DM1 to be cost effective Rx in HER2+ MBC https://t.co/uz0AiU4CuU @ajmontero_MD
2,957 followers
RT @GlopesMd: Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
38,035 followers
RT @GlopesMd: Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
13 followers
RT @GlopesMd: Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
1,354 followers
RT @GlopesMd: Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
1,080 followers
RT @GlopesMd: Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
38,035 followers
Is the whole spectrum of antiHER2 therapies cost effective? Find out in our new paper. https://t.co/b0QHCUwiQn
1,051 followers
Cost-effectiveness analysis of 1st through 3rd line sequential targeted therapy in HER2-positive… https://t.co/Dce0lFkqre #breastcancer